Cargando…
CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy
The aim of this study was to evaluate the cartilage intermediate layer protein 1 (CILP1) as a biomarker of right ventricular dysfunction in patients with ischemic cardiomyopathy (ICM). CILP1 plasma concentrations were measured in 98 patients with ICM and 30 controls without any cardiac abnormalities...
Autores principales: | Keranov, Stanislav, Jafari, Leili, Haen, Saskia, Vietheer, Julia, Kriechbaum, Steffen, Dörr, Oliver, Liebetrau, Christoph, Troidl, Christian, Rutsatz, Wiebke, Rieth, Andreas, Hamm, Christian W., Nef, Holger, Rolf, Andreas, Keller, Till |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052998/ https://www.ncbi.nlm.nih.gov/pubmed/35506075 http://dx.doi.org/10.1002/pul2.12062 |
Ejemplares similares
-
Application and Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio in Patients with Ischemic and Non-Ischemic Cardiomyopathy
por: Keranov, Stanislav, et al.
Publicado: (2021) -
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension
por: Widmann, Laila, et al.
Publicado: (2023) -
The adipokine fatty-acid binding protein 4 and cardiac remodeling
por: von Jeinsen, Beatrice, et al.
Publicado: (2020) -
Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA
por: Lipps, Christoph, et al.
Publicado: (2019) -
Vascular alterations among male elite athletes recovering from SARS-CoV-2 infection
por: Bauer, Pascal, et al.
Publicado: (2022)